Lipid-lowering agent: Difference between revisions
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
|販売 | |販売 | ||
|[[Takeda Pharmaceutical Company]] | |[[Takeda Pharmaceutical Company]] | ||
| | |||
|- | |||
|[[Ethyl eicosapentaenoic acid/ja]] | |||
|[https://med.mochida.co.jp/medicaldomain/circulatory/epadel/index.html エパデール](持田製薬) ([https://med.mochida.co.jp/txt/pdf/epa-s_n22.pdf PI]) ([https://med.mochida.co.jp/interview/epas_n22.pdf IF]) | |||
|販売 | |||
|[[Mochida Pharmaceutical]] | |||
| | | | ||
|- | |- | ||